Alzheimer setback- Roche’s candidate drug fails two trials Subject : Science and Technology Context- Roche’s Alzheimer’s drug candidate could not be shown to slow dementia progression in two drug trials. The study The twin studies (Graduate 1 and 2) failed to show that the drug gantenerumab could preserve abilities such as remembering, solving […]